Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
153M
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
4.12M
-
Shares change
-
+144K
-
Total reported value, excl. options
-
$6.96M
-
Value change
-
-$1.33M
-
Number of buys
-
16
-
Number of sells
-
-16
-
Price
-
$1.69
Significant Holders of BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) as of Q1 2022
40 filings reported holding BDSX - BIODESIX INC - Common Stock, par value $0.001 per share as of Q1 2022.
BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.12M shares
of 153M outstanding shares and own 2.69% of the company stock.
Largest 10 shareholders include Birchview Capital, LP (1.25M shares), BlackRock Inc. (570K shares), WELLS FARGO & COMPANY/MN (550K shares), VANGUARD GROUP INC (220K shares), Cannell & Co. (206K shares), GEODE CAPITAL MANAGEMENT, LLC (180K shares), MILLENNIUM MANAGEMENT LLC (142K shares), STATE STREET CORP (140K shares), FRED ALGER MANAGEMENT, LLC (134K shares), and Endurant Capital Management LP (131K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.